Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
CGEM on Nasdaq
There are no Buy or Sell transactions made by UBS Oncology Impact Fund L.P. since 14 Feb 2025
Holdings reported by UBS Oncology Impact Fund L.P. for Cullinan Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
7,648,268 |
$95,297,419 |
$12.46 |
16 Sep 2021 |
Direct |
|
|
Transactions reported by UBS Oncology Impact Fund L.P. for Cullinan Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.